explore -WSS

explore

author：comprehensive 2025-09-27 15:20:58 - browse：5

Susan Tousi is leaving Illumina to become CEO of cancer liquid-biopsy startup Delfi. Nasdaq

Delfi Diagnostics, a startup devising new ways to use routine blood draws to detect early signs of cancer, told STAT Thursday that it has appointed Susan Tousi, chief commercial officer for genomics giant Illumina, as its new CEO. She is the fourth senior executive to leave Illumina since June.

Tousi will start next week, just in time for the J.P. Morgan Healthcare Conference, while founding CEO Victor Velculescu will remain on the company’s board to help guide its research programs. Tousi’s selection is part of a bid by Delfi to expand its commercial efforts and build on the initial launch of its lung cancer screening test last fall, the latest example of growing interest in the vast and increasingly competitive liquid biopsy market.

Illumina’s own ambitions to enter this space recently came undone after a prolonged battle with U.S. and European regulators finally pushed the company to announce last month that it would divest Grail, which it had acquired for $8 billion two years earlier. Bas Verhoef, Illumina’s head of region for Europe, will serve as interim chief commercial officer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

hotspot

knowledge

WSS

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

6 phony surgeries that take placebo to the extreme

Biden’s NIH nominee is languishing in Congress

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Wikipedia

explore

hotspot

Apple is now the first public company to be valued at $3 trillion

Biden declares emergency in flood

Tori Bowie and the unacceptable rates of Black maternal death

Create a giant ice tray with this foil pan hack to keep food cold this summer

Psychedelics group wrestles with new pharma identity

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Hepatitis C has a cure — but many Americans still lack access to it

ACA's risk program benefits Blue Cross Blue Shield insurers

Peter Hotez and the public health issue of online harassment

PBM reform efforts get punted in Congress

explore

Community Health Systems hospitals under DOJ investigation

Wisconsin governor employs partial veto to fund schools for 4 centuries

Teachers share how revamped forgiveness program helped with their student loans

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Biden declares emergency in flood

hotspot

knowledge

knowledge

knowledge